Back to Search
CALVIN COHEN, M.D.
M.D.
Internal Medicine Physician
NPI: 1063484426Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.
PMID 19114852·AIDS·2009
3-trial
Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study.
PMID 18294111·Pharmacotherapy·2008
3-trial
Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations.
PMID 16265768·AIDS Read·2005
6-review
Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial.
PMID 16238909·Curr Med Res Opin·2005
4-observational
Ritonavir-boosted protease inhibitors, Part 1: strategies for balancing efficacy with effects on lipids.
PMID 16170876·AIDS Read·2005
8-other
Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimen.
PMID 15319673·J Acquir Immune Defic Syndr·2004
3-trial
First-line treatment in HIV: many paths to success.
PMID 12946063·J Acquir Immune Defic Syndr·2003
6-review
Long-term treatment with subcutaneous T-20, a fusion inhibitor, in HIV-infected patients: patient satisfaction and impact on activities of daily living.
PMID 12194730·AIDS Patient Care STDS·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 133 BROOKLINE AVE, INTERNAL MEDICINE
BOSTON, MA 02215 - Phone
- (617) 421-5804
Quick Facts
- NPI
- 1063484426
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile